Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record, with a small difference in title or year; 29 of the 29 references it cites were found in a registry or an index.

Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

Abstract

To evaluate the effects of vasodilator therapy on mortality among patients with chronic congestive heart failure, we randomly assigned 642 men with impaired cardiac function and reduced exercise tolerance who were taking digoxin and a diuretic to receive additional double-blind treatment with placebo, prazosin (20 mg per day), or the combination of hydralazine (300 mg per day) and isosorbide dinitrate (160 mg per day). Follow-up averaged 2.3 years (range, 6 months to 5.7 years). Mortality over the entire follow-up period was lower in the group that received hydralazine and isosorbide dinitrate than in the placebo group. This difference was of borderline statistical significance. For mortality by two years, a major end point specified in the protocol, the risk reduction among patients treated with both hydralazine and isosorbide dinitrate was 34 percent (P less than 0.028). The cumulative mortality rates at two years were 25.6 percent in the hydralazine--isosorbide dinitrate group and 34.3 percent in the placebo group; at three years, the mortality rate was 36.2 percent versus 46.9 percent. The mortality-risk reduction in the group treated with hydralazine and isosorbide dinitrate was 36 percent by three years. The mortality in the prazosin group was similar to that in the placebo group. Left ventricular ejection fraction (measured sequentially) rose significantly at eight weeks and at one year in the group treated with hydralazine and isosorbide dinitrate but not in the placebo or prazosin groups. Our data suggest that the addition of hydralazine and isosorbide dinitrate to the therapeutic regimen of digoxin and diuretics in patients with chronic congestive heart failure can have a favorable effect on left ventricular function and mortality.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm198606123142404

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Research works printed but not linked: 1

  1. Dixon WJ, ed. BMDP statistical software. Berkeley, Calif.: University of California Press, 1981:557–75.

Cited by

See all 2,400

Metadata

Authors
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., Goldman, S., Cobb, F. R., Shah, P. M., Saunders, R., Fletcher, R. D., Loeb, H. S., Hughes, V. C., & Baker, B.
Affiliations
University of Minnesota (US)
Venue
New England Journal of Medicine
Published
1986-06-12
Volume
314
Issue
24
Pages
1547-1552
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2157973908
Cited by
2,400
References
29
Citations by year
2026: 10 · 2025: 20 · 2024: 24 · 2023: 41 · 2022: 38 · 2021: 45 · 2020: 36 · 2019: 35 · 2018: 44 · 2017: 45 · 2016: 48 · 2015: 40 · 2014: 46 · 2013: 48 · 2012: 60
FWCI
78.67
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords
chronic congestive heart failure, vasodilator therapy, hydralazine, isosorbide dinitrate, prazosin, mortality, left ventricular ejection fraction, digoxin, diuretics, left ventricular function
MeSH terms
Clinical Trials as Topic, Drug Therapy, Combination, Exercise Test, Follow-Up Studies, Heart Failure, Hemodynamics, Humans, Hydralazine, Isosorbide Dinitrate, Male, Middle Aged, Prazosin, Random Allocation, Vasodilator Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. https://app.cochat.ai/papers/10.1056/nejm198606123142404
The paper
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., Goldman, S., Cobb, F. R., Shah, P. M., Saunders, R., Fletcher, R. D., Loeb, H. S., Hughes, V. C., & Baker, B. (1986). Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. New England Journal of Medicine. https://doi.org/10.1056/nejm198606123142404

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.